• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.79% Nasdaq Up0.53%

    Regulus Therapeutics Inc. (RGLS)

    -NasdaqGM
    10.54 Down 0.42(3.83%) Jul 1, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 4,200   4,219   1,083   736  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,200   4,219   1,083   736  
    Operating Expenses
    Research Development13,427  10,474  10,173  10,795  
    Selling General and Administrative3,644  3,278  2,569  2,954  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (12,871) (9,533) (11,659) (13,013)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,612)(12,627)1,871  1,050  
    Earnings Before Interest And Taxes(14,483)(22,160)(9,788)(11,963)
    Interest Expense8  8  10  10  
    Income Before Tax(14,491)(22,168)(9,798)(11,973)
    Income Tax Expense(4) -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(14,487)(22,168)(9,798)(11,973)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (14,487) (22,168) (9,798) (11,973)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (14,487) (22,168) (9,798) (11,973)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.